Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
July 24, 2019 - The FDA announced the approval of Eli Lilly’s Baqsimi (glucagon) nasal powder, for the treatment of severe hypoglycemia in patients with diabetes ages 4 years and above.
